-
Je něco špatně v tomto záznamu ?
Measles immunity in a Czech tertiary care hospital
L. Štěpánek, M. Nakládalová, A. Boriková, D. Horáková, L. Štěpánek
Jazyk angličtina Země Nizozemsko
Typ dokumentu časopisecké články, práce podpořená grantem
Nursing & Allied Health Database (ProQuest) od 2002-01-01 do Před 2 měsíci
Health & Medicine (ProQuest) od 2002-01-01 do Před 2 měsíci
Family Health Database (ProQuest) od 2002-01-01 do Před 2 měsíci
Health Management Database (ProQuest) od 2002-01-01 do Před 2 měsíci
Public Health Database (ProQuest) od 2002-01-01 do Před 2 měsíci
Odkazy
PubMed
32127226
DOI
10.1016/j.vaccine.2020.02.067
Knihovny.cz E-zdroje
- MeSH
- centra terciární péče MeSH
- dospělí MeSH
- lidé MeSH
- personál nemocniční * MeSH
- protilátky virové krev MeSH
- séroepidemiologické studie MeSH
- spalničková vakcína MeSH
- spalničky epidemiologie imunologie MeSH
- vakcinace MeSH
- Check Tag
- dospělí MeSH
- lidé MeSH
- mužské pohlaví MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- Geografické názvy
- Česká republika MeSH
BACKGROUND: Given the increasing incidence of measles, the aim was to assess the seroprevalence of measles immunity among employees of a Czech tertiary care hospital and to assess their willingness to revaccination. METHODS: 3027 hospital employees (2421 females, 606 males) underwent a serological analysis of their measles antibody levels with an option of revaccination in case of an insufficient level. RESULTS: The median age of participants was 42 years. Seropositivity was noted in 54% of the participants, with the antibody values higher in the oldest study participants and with a decrease around the birth year 1968. Logistic regression analysis confirmed a significant relationship of seropositivity with age (odds ratio 0.97, p < 0.005). Out of the seronegative, 80.9% individuals got revaccinated. CONCLUSIONS: 46% of the participants did not reach a sufficient antibody level set by the assay's manufacturer. Although the routine vaccination system is well established it may be ineffective.
- 000
- 00000naa a2200000 a 4500
- 001
- bmc21020679
- 003
- CZ-PrNML
- 005
- 20210830102305.0
- 007
- ta
- 008
- 210728s2020 ne f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.vaccine.2020.02.067 $2 doi
- 035 __
- $a (PubMed)32127226
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a ne
- 100 1_
- $a Štěpánek, Ladislav $u Department of Occupational Medicine, University Hospital Olomouc and Faculty of Medicine and Dentistry, Palacký University Olomouc, I. P. Pavlova 185/6, 779 00 Olomouc, Czech Republic. Electronic address: ladislav.stepanek@fnol.cz
- 245 10
- $a Measles immunity in a Czech tertiary care hospital / $c L. Štěpánek, M. Nakládalová, A. Boriková, D. Horáková, L. Štěpánek
- 520 9_
- $a BACKGROUND: Given the increasing incidence of measles, the aim was to assess the seroprevalence of measles immunity among employees of a Czech tertiary care hospital and to assess their willingness to revaccination. METHODS: 3027 hospital employees (2421 females, 606 males) underwent a serological analysis of their measles antibody levels with an option of revaccination in case of an insufficient level. RESULTS: The median age of participants was 42 years. Seropositivity was noted in 54% of the participants, with the antibody values higher in the oldest study participants and with a decrease around the birth year 1968. Logistic regression analysis confirmed a significant relationship of seropositivity with age (odds ratio 0.97, p < 0.005). Out of the seronegative, 80.9% individuals got revaccinated. CONCLUSIONS: 46% of the participants did not reach a sufficient antibody level set by the assay's manufacturer. Although the routine vaccination system is well established it may be ineffective.
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a protilátky virové $x krev $7 D000914
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a spalničky $x epidemiologie $x imunologie $7 D008457
- 650 _2
- $a spalničková vakcína $7 D008458
- 650 12
- $a personál nemocniční $7 D010564
- 650 _2
- $a séroepidemiologické studie $7 D016036
- 650 _2
- $a centra terciární péče $7 D062606
- 650 _2
- $a vakcinace $7 D014611
- 651 _2
- $a Česká republika $x epidemiologie $7 D018153
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Nakládalová, Marie $u Department of Occupational Medicine, University Hospital Olomouc and Faculty of Medicine and Dentistry, Palacký University Olomouc, I. P. Pavlova 185/6, 779 00 Olomouc, Czech Republic. Electronic address: marie.nakladalova@fnol.cz
- 700 1_
- $a Boriková, Alena $u Department of Occupational Medicine, University Hospital Olomouc and Faculty of Medicine and Dentistry, Palacký University Olomouc, I. P. Pavlova 185/6, 779 00 Olomouc, Czech Republic. Electronic address: alena.borikova@fnol.cz
- 700 1_
- $a Horáková, Dagmar $u Department of Public Health, Faculty of Medicine and Dentistry, Palacký University Olomouc, Hněvotínská 976/3, 775 15 Olomouc, Czech Republic. Electronic address: dagmar.horakova@upol.cz
- 700 1_
- $a Štěpánek, Lubomír $u Institute of Biophysics and Informatics, First Faculty of Medicine, Charles University, Salmovská 1, 120 00 Praha 2, Czech Republic. Electronic address: Lubomir.Stepanek@lf1.cuni.cz
- 773 0_
- $w MED00004631 $t Vaccine $x 1873-2518 $g Roč. 38, č. 14 (2020), s. 2889-2892
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/32127226 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20210728 $b ABA008
- 991 __
- $a 20210830102305 $b ABA008
- 999 __
- $a ok $b bmc $g 1691286 $s 1141125
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2020 $b 38 $c 14 $d 2889-2892 $e 20200229 $i 1873-2518 $m Vaccine $n Vaccine $x MED00004631
- LZP __
- $a Pubmed-20210728